Quantitative mutant analysis of viral quasispecies by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry

被引:35
作者
Amexis, G
Oeth, P
Abel, K
Ivshina, A
Pelloquin, F
Cantor, CR
Brau, A
Chumakov, K
机构
[1] US FDA, Ctr Biol Evaluat & Res, Rockville, MD 20852 USA
[2] SEQUENOM Inc, Genom Dept, San Diego, CA 92121 USA
[3] Aventis Pasteur, F-69280 Marcy Letoile, France
关键词
D O I
10.1073/pnas.211423298
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
RNA viruses exist as quasispecies, heterogeneous and dynamic mixtures of mutants having one or more consensus sequences. An adequate description of the genomic structure of such viral populations must include the consensus sequence(s) plus a quantitative assessment of sequence heterogeneities. For example, in quality control of live attenuated viral vaccines, the presence of even small quantities of mutants or revertants may indicate incomplete or unstable attenuation that may influence vaccine safety. Previously, we demonstrated the monitoring of oral poliovirus vaccine with the use of mutant analysis by PCR and restriction enzyme cleavage (MAPREC). In this report, we investigate genetic variation in live attenuated mumps virus vaccine by using both MAPREC and a platform (DNA MassArray) based on matrix-assisted laser desportion/ionization time-of-flight (MALDI-TOF) mass spectrometry. Mumps vaccines prepared from the Jeryl Lynn strain typically contain at least two distinct viral substrains, JL1 and JL2, which have been characterized by full length sequencing. We report the development of assays for characterizing sequence variants in these substrains and demonstrate their use in quantitative analysis of substrains and sequence variations in mixed virus cultures and mumps vaccines. The results obtained from both the MAPREC and MALDI-TOF methods showed excellent correlation. This suggests the potential utility of MALDI-TOF for routine quality control of live viral vaccines and for assessment of genetic stability and quantitative monitoring of genetic changes in other RNA viruses of clinical interest.
引用
收藏
页码:12097 / 12102
页数:6
相关论文
共 33 条
[1]   HETEROGENOUS MUMPS VACCINE [J].
AFZAL, MA ;
PICKFORD, AR ;
FORSEY, T ;
MINOR, PD .
LANCET, 1992, 340 (8825) :980-981
[2]   Correlation of genetic variability with safety of mumps vaccine Urabe AM9 strain [J].
Amexis, G ;
Fineschi, N ;
Chumakov, K .
VIROLOGY, 2001, 287 (01) :234-241
[3]  
Braun A, 1997, CLIN CHEM, V43, P1151
[4]   Improved analysis of microsatellites using mass spectrometry [J].
Braun, A ;
Little, DP ;
Reuter, D ;
MullerMysok, B ;
Koster, H .
GENOMICS, 1997, 46 (01) :18-23
[5]   NUCLEOTIDE-SEQUENCE ANALYSIS OF URABE MUMPS VACCINE STRAIN THAT CAUSED MENINGITIS IN VACCINE RECIPIENTS [J].
BROWN, EG ;
FURESZ, J ;
DIMOCK, K ;
YAROSH, W ;
CONTRERAS, G .
VACCINE, 1991, 9 (11) :840-842
[6]  
Brown EG, 1998, REV MED VIROL, V8, P129, DOI 10.1002/(SICI)1099-1654(199807/09)8:3&lt
[7]  
129::AID-RMV213&gt
[8]  
3.0.CO
[9]  
2-Z
[10]   High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry [J].
Buetow, KH ;
Edmonson, M ;
MacDonald, R ;
Clifford, R ;
Yip, P ;
Kelley, J ;
Little, DP ;
Strausberg, R ;
Koester, H ;
Cantor, CR ;
Braun, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (02) :581-584